Cargando…
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
BACKGROUND: End-stage renal disease (ESRD) is the final stage during the development of renal failure. Depression is the most common psychiatric disorder in patients with ESRD, which in turn aggravates the progression of renal failure, however, its underlying mechanism remains unclear. This study ai...
Autores principales: | Yuan, Dezhi, Kuan, Tian, Ling, Hu, Wang, Hongkai, Feng, Liping, Zhao, Qiuye, Li, Jinfang, Ran, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567927/ https://www.ncbi.nlm.nih.gov/pubmed/34723750 http://dx.doi.org/10.1080/0886022X.2021.1994995 |
Ejemplares similares
-
Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis
por: Li, Rong, et al.
Publicado: (2019) -
Effect of roxadustat on serum metabolome and lipidome in patients with end-stage renal disease and erythropoiesis-stimulating agent resistance
por: Wang, Lichao, et al.
Publicado: (2022) -
Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder
por: Gao, Wenfan, et al.
Publicado: (2022) -
Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients
por: Lee, Wan Soo, et al.
Publicado: (2015) -
Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019)